Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effect of Quercetin on Iron Overload and Inflammation in Β-Thalassemia Major Patients: A Double-Blind Randomized Clinical Trial Publisher Pubmed



Sajadi Hezaveh Z1 ; Azarkeivan A2 ; Janani L3 ; Hosseini S4 ; Shidfar F1
Authors

Source: Complementary Therapies in Medicine Published:2019


Abstract

Objectives: The aim of this study was to determine whether quercetin can reduce iron overload and inflammation in thalassemic patients. Methods: Eighty four patients were recruited to this study and randomly assigned to two groups: 42 patients received a 500 mg/day quercetin tablet and 42 others took a 500 mg/day starch placebo for 12 weeks. Demographic, anthropometric and biochemical evaluation were performed. Results: ANCOVA analysis revealed that compared to the control group, quercetin could reduce high sensitivity C-reactive protein (hs-CRP) (P = 0.046), iron (p = 0.036), ferritin (p = 0.043), and transferrin saturation (TS) (p = 0.008) and increase transferrin (p = 0.045) significantly, but it had no significant effect on total iron binding capacity (TIBC) (p = 0.734) and tumor necrosis factor α (TNF-α) (p = 0.310). Conclusions: Quercetin could ameliorate the iron status in thalassemia major, but its effect on inflammation is indistinctive. © 2019 Elsevier Ltd
Other Related Docs
7. Renal Hemosiderosis Among Iranian Transfusion Dependent Β-Thalassemia Major Patients, International Journal of Hematology-Oncology and Stem Cell Research (2017)